<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220119053766N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-03-17</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences- faculty of dentistry</primary_sponsor>
      <public_title>Evaluating the effect of photobiomodulation therapy with diode laser on peri-implant soft tissue healing following uncovering.</public_title>
      <acronym></acronym>
      <scientific_title>Evaluating the effect of photobiomodulation therapy with 445 nm diode laser on peri-implant soft tissue healing following uncovering: a triple-blind, split-mouth, randomized controlled trial.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-07-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>10</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/61528</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Using a simple randomized method, one side of the mouth is considered as the intervention area and the other side of the mouth is considered as the control. A randomization list will be prepared by the statistics consultant using the RAND function in Excel software and will be provided to the researcher. In the intervention area, the soft tissue around the desired dental implant will be exposed by laser. In the control area, the laser device probe will be used in off mode in the soft tissue area around the desired dental implant, Blinding description: In this study, the patient, the evaluator (consisting of two periodontists and a maxillofacial surgeon who measures the outcomes of the study based on the EHS index), and the statistical analyst (statistics consultant) will be blinded by the intervention and control.
During laser treatment, goggles are placed on the patient's eyes. The patient will not feel any heat changes or pain during the laser treatment. The device probe is used on the control side at the same time as intended on the intervention side in off mode. The patient (according to the above points) will be blind to which side of the mouth he receives the laser. The laser operator is not blind to the assignment of the laser to either side of the mouth, but the person measuring the results of the study will be blind to this assignment. Also, labels A and B are considered for both intervention and control so that the statistical analyst is blind to the end of the data analysis relative to the allocation.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Evaluating the effect of photobiomodulation therapy with 445 nm diode laser on peri-implant soft tissue healing following uncovering.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:Initially, to start the process; local anesthesia with local infiltration technique in the maxilla or inferior alveolar nerve block in the mandible with 2% lidocaine anesthetic solution and epinephrine 1/100000 (Elixir Pharmaceutical Company, 1.8 ml)will be done . After uncovering by a surgeon with midcrestal incision and mucoperiosteal flap elevation and healing abutment insertion(after three months) with absorptive sutures  (vicryl 000, 19 mm, reverse cut) by simple interrupted method (one in front And another behind the healing), on days zero (immediately after surgery), third, seventh and fourteenth after surgery with a 445 nm blue diode laser with specifications (SIRO Laser Blue, Sirona Dental SystemsGmbH, Bensheim, Germany) at a power of 200 mW and in continuous wave mode with handpiece therapy to a cross section of 0.5 cm2 for 15 seconds and a density energy of 6 J / cm2 will be irradiated by a laser operator (one of the researchers) in each of the two buccal and lingual areas. Intervention 2: Control group:In the control area, the laser device probe will be used in off mode in the soft tissue area around the desired dental implant.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Data file and statistical analysis will be shared

When:
3 months after data collection

To whom:
The above information will be made available to the public in the form of appendices along with the published article

Conditions:
To better understand the study findings as well as a reference for future studies.

Where to obtain:
website of the journal where the article will be published.

How to obtain:
The data file and statistical analysis will be available to everyone

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Nima Dehghani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>North Karegar  St,Tehran-Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>14399-55991 P.O.BOX:</zip>
        <telephone>+98 21 8801 5801</telephone>
        <email>nimadt2002@yahoo.com</email>
        <affiliation>Tehran University of Medical Sciences- School of Dentistry</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Nima Dehghani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>North Karegar  St,Tehran-Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>14399-55991 P.O.BOX:</zip>
        <telephone>+98 21 8801 5801</telephone>
        <email>nimadt2002@yahoo.com</email>
        <affiliation>Tehran University of Medical Sciences- School of dentistry</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1) Patients who have received dental implants in a two-stage (conventional) method, bilaterally in one jaw(maxilla or mandible), and need healing abutment of a same size.
2) People over 18 years old.
3) No smoking, tobacco and other tobacco and alcohol consumption in the last six months.
4) Patients who have a good oral hygiene. (Patients are evaluated with O'Leary plaque index; and plaque index less than 10% is considered as good oral hygiene).
5) bleeding score less than 25% in 6 areas of each tooth
6)  No history of periodontal treatment in the surgical area in the past year.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1) Patients with uncontrolled systemic disease (uncontrolled diabetes, immunodeficiency and uncontrolled periodontal disease).
2) Pregnant and lactating women.
3) People allergic to the drugs used in the study.
4) History of IV bisphosphonates consumption during the past three years and oral mode over ten years.
5) History of radiotherapy and chemotherapy in the head and neck area.
6) People who need advanced soft tissue management procedures (patients who have soft tissue defects or have extra soft tissue in the area).
7) Candidates of fresh socket implant method.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:Initially, to start the process; local anesthesia with local infiltration technique in the maxilla or inferior alveolar nerve block in the mandible with 2% lidocaine anesthetic solution and epinephrine 1/100000 (Elixir Pharmaceutical Company, 1.8 ml)will be done . After uncovering by a surgeon with midcrestal incision and mucoperiosteal flap elevation and healing abutment insertion(after three months) with absorptive sutures  (vicryl 000, 19 mm, reverse cut) by simple interrupted method (one in front And another behind the healing), on days zero (immediately after surgery), third, seventh and fourteenth after surgery with a 445 nm blue diode laser with specifications (SIRO Laser Blue, Sirona Dental SystemsGmbH, Bensheim, Germany) at a power of 200 mW and in continuous wave mode with handpiece therapy to a cross section of 0.5 cm2 for 15 seconds and a density energy of 6 J / cm2 will be irradiated by a laser operator (one of the researchers) in each of the two buccal and lingual areas.</i_keyword>
      <i_keyword>Control group:In the control area, the laser device probe will be used in off mode in the soft tissue area around the desired dental implant</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Early Wound Healing Score (EHS). Timepoint: Days 3, 7, 14 before the laser and also in the 21st day session. Method of measurement: By the Early Wound Healing Score (EHS) in the data collection form.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Patient evaluation of pain and discomfort in the surgical area. Timepoint: On each of the 3, 7, 14 days before the laser and also on the 21st day after surgery. Method of measurement: Assessment of pain and discomfort in the surgical area, which is scored by the patient himself with a visual analog scale in the form of a 10 cm linear segment. The lowest score indicates the least pain and the highest score indicates the most pain and discomfort in the surgical area.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences- faculty of dentistry</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-10-30</approval_date>
        <contact_name>Ethics committee of Tehran University of Medical Sciences-faculty of dentistry</contact_name>
        <contact_address>North Karegar  St,Tehran-Iran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
